Investor Relations

Latest Financial Results

FY 2023

Fiscal Year Ended Dec 31, 2023

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Company Overview

Cryoport, Inc., is a global provider of innovative products and services to the fast-growing Cell & Gene Therapy industry - enabling the future of medicine for a new era of life sciences. With 50 strategic locations covering the Americas, EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific), Cryoport's global platform provides mission-critical bio-logistics, bio-storage, bio-processing, and cryogenic systems to the life sciences markets worldwide.

Stock Snapshot

IR Contacts

Headquarters

Cryoport, Inc.
112 Westwood Place
Suite 350
Brentwood, TN 37027

Investor Relations

Scott Eckstein
seckstein@kcsa.com

Todd Fromer
tfromer@kcsa.com

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
8th Floor
New York, NY 10004
T: 212-509-4000